2-es típusú cukorbetegség: vizsgálatok itt: Japán
31 trials · From ClinicalTrials.gov, checked 2026. november 14.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Aichi, Kariya, Aichi, Kasugai, Aichi, Nagoya, Chiba, Chiba, Chiba, Ichikawa, Chiba, Matsudo, Chiba, Narashino, Ehime, Matsuyama, Fukuoka, Chikushino, Fukuoka, Fukuoka, Gumma, Maebashi, Gumma, Takasaki, Hiroshima, Hiroshima, Hiroshima, Kure, Hokkaido, Asahikawa, Hokkaido, Sapporo, Hyogo, Nishinomiya, Ibaraki, Higashiibaraki-gun, Ibaraki, Mito, Ibaraki, Naka, Ibaraki, Tsukuba, Ishikawa, Kanazawa, Iwate, Morioka, Kagawa, Kanonji, Kagawa, Takamatsu, Kagoshima, Kagoshima, Kanagawa, Miura-gun, Kanagawa, Sagamihara, Kanagawa, Yokohama, Kochi, Kochi, Kumamoto, Kumamoto, Kumamoto, Kyoto, Kyoto, Miyagi, Sendai, Miyazaki, Miyakonojo, Nagano, Matsumoto, Nagasaki, Nagasaki, Okayama, Okayama, Osaka, Daito, Osaka, Matsubara, Osaka, Moriguchi, Osaka, Osaka, Osaka, Suita, Saitama, Ageo, Saitama, Koshigaya, Saitama, Saitama, Saitama, Tokorozawa, Shizuoka, Fujieda, Shizuoka, Sunto-gun, Tochigi, Shimotsuga-gun, Tochigi, Shimotsuke, Tokushima, Tokushima, Tokyo, Hachioji, Tokyo, Itabashi-ku, Tokyo, Minato-ku, Tokyo, Ota-ku, Toyama, Toyama, Toyoake-shi
- Életkor
- 18 év and over
- People
- 11 800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - 3. fázisNot yet taking people in JapánA Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
- Where
- Chiba-shi, Chiba, Suita-shi, Tokyo
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931495 · EU 2026-525470-18-00 - 3. fázisNot yet taking people in JapánA Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or Both
- Where
- Aichi, Arakawa-ku, Tokyo, Chiba-shi, Chiba, Chikushino-shi, Fukuoka, Gifu, Ibaraki, Kamakura-shi, Kanagawa, Koriyama-shi, Fukushima, Minato-ku, Tokyo, Mito-shi, Ibaraki, Oita-shi, Oita,, Sendai, Miyagi, Tamana-shi, Kumamoto, Tokyo, Tsu-shi, Mie, Wakayama
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931547 · EU 2026-525471-13-00 - 3. fázisNot yet taking people in JapánA Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or Both
- Where
- Aichi, Chiba-shi, Chiba, Hokkaido, Koriyama-shi, Fukushima, Shinjuku-ku, Tokyo, Suita-shi, Tokyo
- Életkor
- 18 év and over
- People
- 1060 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931599 · EU 2026-525474-20-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Aichi, Fukuoka, Hokkaido, Osaka, Tokyo
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Aichi, Fukuoka, Hokkaido, Osaka, Tokyo
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Chūōku, Ichinomiya-shi, Izunokuni-shi, Kamakura-shi, Kawagoe-shi, Kitakyushu-shi, Kyoto, Mito, Nishinomiya-shi, Ōmihachiman, Yokohama
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00 - No phaseTaking peopleAn Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
- Where
- Many Locations
- Életkor
- 18 év and over
- People
- 50 000 worldwide
- Run by
- Bayer
See details and how to joinNCT06278207 - 3. fázisTaking peopleA Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Where
- Chuo-ku, Shinjuku-ku, Suita
- Életkor
- 18 év and over
- People
- 954 worldwide
- Run by
- Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00 - 3. fázisTaking peopleA Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
- Where
- Chiyoda-ku, Fukuoka, Iruma, Moriyama, Niigata, Osaka, Saitama, Sendai, Shizuoka, Tokyo, Urayasu
- Életkor
- 10 év to 17 év
- People
- 170 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07668336 · EU 2025-524811-35-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Where
- Chigasaki, Chūōku, Kamakura, Kasuya-gun, Kawaguchi, Kita-ku, Mihama-ku,Chiba City, Naha, Oyama, Setagaya-ku, Sōka, Tsuchiura, Ushiku, Yokohama
- Életkor
- 18 év and over
- People
- 1035 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Where
- Chūōku, Izumisano, Kawasaki, Kisarazu, Kure, Kyoto, Matsuyama, Osaka, Sapporo, Shimonoseki, Wakayama
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00 - 3. fázisTaking peopleA Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Chūōku, Narashino, Sōka, Tsuchiura
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00 - 2. fázisTaking peopleA Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Where
- Hachiōji, Kamakura-shi, Naka, Narita
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07783802 - 3. fázisNot yet taking people in JapánA Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
- Where
- Chiyoda City, Chūōku, Kawasaki, Kin-cho, Kunigami-gun, Nerima-ku, Shinjuku, Shinjuku-ku, Urasoe
- Életkor
- 18 év and over
- People
- 2115 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881432 · EU 2026-526047-34-00 - 3. fázisNot yet taking people in JapánA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Hamadayama, Suginami-ku, Himeji, Kisarazu, Kōriyama, Kumamoto, Kurume, Osaka, Shinjyuku, Uji
- Életkor
- 45 év to 64 év
- People
- 3000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Where
- Chūōku, Fukuoka, Hachioji-shi, Ichikawa-shi, Kamakura-shi, Kishiwada-shi, Kitakyushu, Meguro-ku, Mito, Sapporo, Shinjuku-ku, Soka-shi, Tama-shi, Yamato-shi, Yokohama
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Chūōku, Fukuoka, Hachioji-shi, Osaka, Shibuya-ku, Takatsuki-shi
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Where
- Aira, Chūōku, Fukuoka, Hachioji-shi, Izunokuni-shi, Kumamoto, Nagoya, Nerima-ku, Osaka, Saga, Sapporo, Shinjuku-ku, Suita-shi, Tanabe-shi
- Életkor
- 18 év and over
- People
- 1500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784270 - 3. fázisTaking peopleA Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Where
- Asahikawa-shi, Chūōku, Kamakura-shi, Koga-shi, Kumamoto, Mitaka-shi, Mito, Miyazaki, Nagoya, Naka, Nishinomiya-shi, Osaka, Sapporo, Takamatsu
- Életkor
- 18 év and over
- People
- 1200 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662213 · EU 2025-523933-24-00 - 3. fázisTaking peopleA Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Amagasaki-shi, Chūōku, Kasugai-shi, Koga-shi, Maebashi, Minatoku, Naka, Shinjuku-ku, Shizuoka, Suita-shi, Toshima-ku, Yamato-shi, Yokohama
- Életkor
- 18 év and over
- People
- 4500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803 - 3. fázisTaking peopleExtension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Where
- Aki-gun, Kashiwara-shi, Kitakyusyu-shi, Kumamoto, Matsuyama, Meguro-ku, Mitaka-shi, Mito, Naka, Shizuoka, Tsuchiura-shi
- Életkor
- 18 év to 99 év
- People
- 950 worldwide
- Run by
- Amgen
See details and how to joinNCT07684144 · EU 2025-524788-19-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Where
- Adachi-ku, Chūōku, Fukuoka, Minato, Mitaka, Suita-shi, Tokyo
- Életkor
- 18 év and over
- People
- 1980 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00 - 2. fázisTaking peopleA Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- Where
- Chiba-shi, Chiba, Ibaraki, Soka-shi, Saitama, Tokyo
- Életkor
- 18 év to 75 év
- People
- 270 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07415954 · EU 2025-523260-20-00 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Where
- Chigasaki-shi, Chikushino-shi, Gifu, Kagoshima, Kitakyushu, Kumamoto, Kyoto, Maebashi, Nagoya, Osaka, Sapporo, Suita-shi, Tachikawa-shi, Toyota-Shi
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00